Sudden Passing of 'OTC Prince' Guan Ping, Architect Behind Caltrate and Bai Jia Hei

Source: Hecheng Release

Recently,New Third Board CompanyYuanhe Pharmaceutical Group Lndustry Co.,ltd.Announcement release,Mr. Guan Ping, a director of the company, passed away unexpectedly on December 1st.He has managed multiple brands such as Caltrate and White Plus Black.

Yuanhe Pharmaceutical Group Lndustry Co.,ltd. expressed that the company's directors, supervisors, senior management, and all employees pay the highest respect and heartfelt thanks to Mr. Guan Ping for his hard work and outstanding contributions during his tenure. We deeply mourn and remember Mr. Guan Ping’s passing and extend our sincere condolences to his family.

According to the 2025 semi-annual report of Yuanhe Pharmaceutical Group Lndustry Co.,ltd., Guan Ping was born in October 1961, holding 500,000 shares of the company, accounting for 0.81% of the total share capital.

Public information shows that Guan Ping isChina MedicineA senior professional manager in the industry, who has won awards such as one of the Top Ten Professional Managers in China and one of the Top Ten Pharmaceutical Elites. He is seen as a teacher and older brother figure by many professional managers, and many people respectfully call him "Lord Guan." He has worked successively at Xian Janssen,Livzon Group, Wyeth Pharmaceuticals, Shijiazhuang Pharmaceutical Group, Dongsheng Technology and other pharmaceutical companies.

It was reported that, during the nascent period of China's pharmaceutical market,Guan Ping, who once managed mega-products such as Caltrate and White Plus Black, has been crowned the "OTC (Over-the-Counter) Prince" in the industry."The title 'Lord Guan' is associated with seniority, age, adherence to rules, dignity in conduct, and carries a sense of self-respect and freedom," said a close friend of Guan Ping in the industry while paying tribute to him in a memorial video.

▌Source of this article：Daily Economic News Comprehensive Public Information, Interface News, China Pharmaceutical News

Editor | Tan YingEditor | Zhang Changyu

Review | Qi YingOverall Planning| Meng Fanyu